Pasithea Therapeutics Corp. · NASDAQ:KTTA
Lawrence Steinman reported a 3.10% stake in Pasithea Therapeutics Corp. (Schedule 13D/A)
Event Mar 1, 2025 · Filed Mar 6, 2025
Lawrence Steinman reported a 3.10% stake in Pasithea Therapeutics Corp., 83,858 shares, with active intent on Mar 1, 2025. Filed Mar 6, 2025 (Schedule 13D/A).
- Stake
- 3.10%
- Shares
- 83,858
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lawrence Steinman | 3.10% | 83,858 |
Source
Related
- Pasithea Therapeutics Corp.
- Lawrence Steinman
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026